Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Assessing Retroperitoneal Fibrosis: A Literature Review | Zendy

Giorgio Treglia | Zendy; Maria Vittoria Mattoli | Zendy; Francesco Bertagna | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Assessing Retroperitoneal Fibrosis: A Literature Review

Author(s) -

Giorgio Treglia,

Maria Vittoria Mattoli,

Francesco Bertagna

Publication year - 2012

Publication title -

international journal of molecular imaging

Language(s) - English

Resource type - Journals

eISSN - 2090-1712

pISSN - 2090-1720

DOI - 10.1155/2012/484052

Subject(s) - medicine , positron emission tomography , fluorodeoxyglucose , nuclear medicine , radiology , pet imaging , positron emission , positron emission tomography computed tomography , medical physics

Background and Purpose . Several studies have evaluated the role of fluorine-18-fluorodeoxyglucose positron emission tomography and positron emission tomography/computed tomography (FDG-PET and PET/CT) in diagnosing and assessing disease activity in patients with retroperitoneal fibrosis (RF). The aim of our paper is to perform a literature review on this topic. Methods . Scientific articles that evaluated the usefulness of FDG-PET and PET/CT in patients with RF were searched and discussed. Results . Eleven studies were found, and the main findings of these articles were described. Conclusion . FDG-PET and PET/CT are useful functional imaging methods for assessing patients with RF both in the diagnosis and in the treatment response evaluation. Moreover, further studies are needed to substantiate the role of FDG-PET and PET/CT in patients with RF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research